cvs

In a second quarter hit by one-time unique charges, CVS Health recorded a company net loss of $2.56 billion, or $2.52 per diluted share, versus company net income of $1.1 billion, or $1.07 per diluted share, in the year-before period.

Adjusted income from continuing operations, excluding unique items, was $1.72 billion, or $1.69 per diluted share, versus $1.36 billion, or $1.33 per diluted share, in the year-previous period. CVS topped a MarketBeat-published analyst consensus estimate of $1.61.

Unique items included a goodwill impairment charge of $3.9 billion associated with the CVS long-term care business as well as $39 million in transaction and integration costs related to the proposed acquisition of Aetna, CVS pointed out.